PDL-1 expression in lung carcinoma and its correlation with clinicopathological and prognostic characteristics

التفاصيل البيبلوغرافية
العنوان: PDL-1 expression in lung carcinoma and its correlation with clinicopathological and prognostic characteristics
المؤلفون: Alyaa R Elsergany, Tamer Elhadidy, Mayada S Farrag, Eman M. Ibrahim, Heba Wagih Abdelwahab
المصدر: Journal of Immunoassay and Immunochemistry. 42:679-690
بيانات النشر: Informa UK Limited, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Lung Neoplasms, animal diseases, medicine.medical_treatment, Clinical Biochemistry, Immunology, chemical and pharmacologic phenomena, Adenocarcinoma, 01 natural sciences, B7-H1 Antigen, Correlation, Immune system, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Carcinoma, Humans, Immunology and Allergy, Medicine, Lung cancer, Lung, business.industry, 010401 analytical chemistry, High mortality, Immunotherapy, biochemical phenomena, metabolism, and nutrition, Prognosis, medicine.disease, 0104 chemical sciences, ErbB Receptors, Medical Laboratory Technology, medicine.anatomical_structure, Cancer research, bacteria, High incidence, business
الوصف: Lung cancers have high incidence and high mortality rates. The immune checkpoints as programmed death ligand 1 (PDL-1) can suppress the tumor immune reaction. So, their blocking seems to be a way to treat tumors. This study assesses PDL-1 immunohistochemical expression in lung cancer, and its correlation with prognosis. It included 62 specimens of lung cancer in Hospitals of Mansoura Faculty of Medicine, Egypt. Seventy-one percent of cases showed positive PDL-1 and about 59.1% of them showed high expression. PDL-1 expression in NSCLC was significantly higher than in SCLC (
تدمد: 1532-4230
1532-1819
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cba655b4844421ee73175c75d4611545Test
https://doi.org/10.1080/15321819.2021.1938606Test
رقم الانضمام: edsair.doi.dedup.....cba655b4844421ee73175c75d4611545
قاعدة البيانات: OpenAIRE